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A B S T R A C T
Lymphomatoid granulomatosis (LG) is currently called as extranodal angiocentric and angiodestructive immuno-
proliferative disorder with various degrees of histological differentiation and disease severity. Histological grading and
clinical manifestations are due to number of atypical large EBV+ B-lymphatic cells. We report the case of a 23-year-old
man clinically presented with fever, sweating, and physical intolerance, and bilateral pulmonary infiltrates of nodular
type and destructive changes on the chest X-ray, previously treated with antituberculotics for 1.5 month. As the disease
showed progression, diagnostic procedures extended to transbronchial lung biopsy and percutaneous fine needle aspira-
tion with cytological and histological analysis of collected specimens, all being not conclusive enough. LG was confirmed
by open lung biopsy, followed by induction of corticosteroids and cyclophosphamide therapy. Very good clinical, func-
tional and radiomorphologic improvement was achieved in a few weeks, and remission of disease maintained in long
term follow-up.
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Introduction
Lymphomatoid granulomatosis (LG) is a rare EBV-
-driven lymphoproliferative disorder, which may prog-
ress to diffuse large B-cell lymphoma (DLBCL)1. LG pre-
dominantly affects the lungs, but also other extrathora-
cic sites such as brain, kidneys, liver and skin. Diagnosis
is difficult and based on histological examination of sam-
ples usually achieved by surgical procedures2,3. Therapy
is based on high-dose steroids associated with cyclopho-
sphamide, and recently used targeted agent rituximab,
which specifically targets the CD 20 antigen on the sur-
face of B-cells4,5.
Case Report
A 23-year-old man previously being healthy referred
to local hospital because of haemoptysis, cough and fever.
He noticed intolerance of physical activity and excessive
sweating for last 3 months. On admission to hospital,
chest X-ray showed multiple nodal and destructive infil-
trations bilaterally, predominantly in the left lung. Labo-
ratory findings revealed sedimentation rate of 17, nor-
mal peripheral blood smear, and negative bacteriologic
tests for non-specific bacteria and M. tuberculosis. Four
regimen antituberculotic therapy was empirically intro-
duced for 1.5 month. In that period, patient’s clinical sta-
tus deteriorated with radiologic progression of bilateral
lung infiltrates. For further diagnostic procedures the
patient was admitted to our Clinic. On appearance, he
was moderately dyspnoeic, pale, sweated, febrile to 37.6
°C, and in a depressive mood. Neurological examination
was normal. Lung auscultation revealed normal breath-
ing sounds with scattered rales bilaterally. Laboratory
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findings showed elevated sedimentation rate (21), lym-
phopenia (0.7 g/L), hypogammmaglobulinaemia (4.09
g/L), elevated liver enzymes (AST 58 U/L, ALT 83 U/L
and GGT 112 U/L), and elevated C-reactive protein (CRP
43 mg/L), whereas the other routine laboratory tests
were all within the normal values. Angiotensin convert-
ing enzyme (ACE), p and c ANCA, autoantibody screen
and test for HIV were negative or normal. Tuberculin
test was negative. Functional testing of respiratory tract
showed restrictive pattern on spirometry (FEV1 65.5%,
FVC 55%) and decreased diffusing CO capacity of 57%.
Bacteriological samples were negative for common cau-
ses, andM. tuberculosis negative in direct smears. Chest
X-ray and chest computed tomography (CT) showed mul-
tiple nodal and destructive, confluenting infiltrates of
both lungs (Figures 1 and 2). Fiberbronchoscopy showed
hyperaemic bronchial mucosa with normal intraluminal
secretion. Bronchoalveolar lavage (BAL) showed a hyper-
cellularity with 95% macrophages and 5% lymphocytes,
and the CD4/CD8 ratio of 1.1. Brushing for cytological
examination was done, followed by transbronchial lung
biopsy of 5 specimens. Cytological findings of biopsy
specimens were non-specific: lymphoid cells, pneumocy-
tes, phagocytes and a few epitheloid cells. Histology of
the same specimens showed lung parenchyma with lym-
phoid cells infiltrations (CD3+ and CD 20+), several in-
tact vessels, and a few lymphoid infiltrations in the small
vessel’s walls. Percutaneous fine needle aspiration of
pulmonary lesions by diascopic X-ray guidance has been
done, and cytological smear showed lymphoid cells, few
epitheloid cells and few large cells with basophilic cyto-
plasm and big nuclei (Figure 3). As cytological and his-
tological findings were inconclusive, the open lung biopsy
of the left lower lobe was performed under mini-tho-
racotomy. In the two biopsy specimens of lung paren-
chyma (4´2´0.7 cm and 3´1´0.2 cm in size) nodular infil-
trates (up to 0.4 cm in diameter) consisted of poly-
morphic lymphoid cells and large cells with big nucleoli
and mitotic activity (proliferation index 20%) were found
(Figure 4). Immunohistochemical study showed that
small lymphocytes were positive for CD3+, CD43+ and
CD 5+, and large lymphatic cells were positive for
CD20+, CD30+ and Epstein-Barr virus (EBV) + cells
5–7/ HPF–1 (Figures 5, 6, and 7). Vessels of greater cali-
bre were intact, but small vessels contained subendo-
thelial foci of lymphocytic infiltration (Figure 8). There
were found no granulomatous formations. The diagnosis
of lymphomatoid granulomatosis was established.
Immediate treatment followed with combination of
corticosteroids in high doses (methilprednisolon 0.8 mg/
kg of body weight) with cyclophosphamide 100 mg/day.
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Fig. 1. A chest radiograph before treatment showing bilateral
multiple nodular infiltrates.
Fig. 2. Sequential CT scans of thorax before treatment.
Multiple nodular confluenting infiltrates, some excavated.
Fig. 3. Fragment of endothelial cells and polymorphic
infiltrate containing small lymphocytes, histiocytes and one
large atypical mononuclear cell beside (May-Grünwald-
-Giemsa stain, x400).
After three weeks of this treatment scheme, rapid and
huge morphological regression of lung infiltrates was
found on chest X-ray (Figure 9), as well as clinical im-
provement. The patient was discharged from the hospi-
tal, and continued taking at home cyclophosphamide in
the same dose for period of 1.5 years, and metilpredni-
solone was maintained after gradually lowering dose to 8
mg/day, and discontinued after 9 months. After three-
-year follow-up, the patient has remained in the remis-
sion, clinically without any symptoms, and with normal
lung function tests and laboratory findings, as well as
normal chest X-ray.
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Fig. 5. Immunohistochemical staining of CD3+
numerous small lymphocytes (x400).
Fig. 6. Immunohistochemical staining of CD20+
large lymphatic cells (x400).
Fig. 4. Pulmonary tissue – nodular lymphocytic
infiltration (H&E, x400).
Fig. 7. Immunohistochemical staining of EBV+
B-lymphatic cells (x400).
Fig. 8. Vasculitis with subendothelial foci of lymphocytic
infiltration (H&E, x400).
Fig. 9. Control chest X-ray after three weeks of treatment.
Total regression of bilateral infiltrates are observed.
Discusion
LG was initially thought to be an inflammatory gra-
nulomatous disease, since its clinicomorphological pre-
sentation is somewhat similar to other granulomatoses,
particularly Wegener’s disease6,7. Currently, LG is de-
fined as an extranodal angiocentric and angiodestructive
immunoproliferative disorder with various degrees of
histological differentiation and severity of clinical mani-
festations. LG usually occurs at age of 30–50 years, with
a marked male predominance7,8. Patients are presented
with systemic and respiratory symptoms, consisting of
fever, weight loss, malaise, cough, dyspnoea, haemoptysis
and chest pain. Disease is multisystemic involving many
organs such as brain, skin, liver and kidneys, lung is the
most frequent site. Radiological imaging by chest X-ray
and CT of thorax are characterized with multiple smooth
nodal infiltrates (occasionally with destructive pattern)
of the lung. Macroscopicaly, LG forms multiple and often
confluent nodules of variable size, which are yellow or
grey on the cut surface with areas of necrosis. Histolo-
gically, pulmonary nodules are composed of an angio-
centric, polymorphous and atypical lymphoid infiltrate
with moderate to extensive necrosis involving arterioles
and veins. Vessels show mural infiltrates of small lym-
phocytes and atypical large cells with vesicular nuclei.
Subendothelial and adventitial zones are infiltrated by
lymphoid cells, and cause erosion and obliteration of the
vessel wall and lumen. Occasionally, granulomatous for-
mations are seen. Central necrosis in the pulmonary nod-
ules may be due to cytokines induced by IL-12, which is
secreted by EBV infected B-cells7,9. Immmunohistoche-
mistry shows T-cell infiltrate (predominantly CD4+
T-lymphocytes) with scattered atypical B-cells. The
5-year survival is 30–40%, although spontaneous resolu-
tion and complete remission ccur occasionally³. The main
prognostic factors are the following: age, extension of le-
sions and histological grading, which is subdivided into
three grades according to the quantity and degree of cel-
lular atypia and presence or absence of necrosis. Mitotic
figures and necrosis may be extensive, and proliferation
index within the B-cell population correlates with the
histological grade2. In addition, histological grade is
shown to be related to number of EBV+ cells10. Our case
is grade II LG comprising in the lesion the EBV+ cells
5–7/HPF–1 and proliferation index of 20%. The quantifi-
cation of number of EBV+ B-cells and proliferation in-
dex is particularly useful in distinguishing grade II LG
from grade III LG3,7, suggesting that only grade III LG
might proliferate to B-cell lymphoma. Our patient might
have a good prognostic outcome regarding age, histo-
logical grade, proliferation index, and very good response
and remission of the disease after introduction and main-
tenance of first line therapy with steroids and cyclo-
phosphamide. Administration of rituximab as a second
line treatment should be considered in the case of reoc-
currence of disease activity in the follow-up of our pa-
tient4,5.
Conclusion
Clinical presentation and radiologic imaging of our
patient, laboratory findings, as well as cytological and
histological examination of specimens achieved by bron-
choscopy, all were not of enough diagnostic value. Open
lung biopsy with more representative specimens of lung
tissue showed nodular infiltrations with EBV+ cells, pro-
liferation index of 20%, and diagnosis of LG grade II was
established. Therapy with steroids and cyclophospha-
mide achieved good and fast control with disease remis-
sion.
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LIMFOMATOIDNA GRANULOMATOZA U 23-GODI[NJEG MLADI]A – CITOLO[KA
I HISTOLO[KA SLIKA I BRZI ODGOVOR NA KOMBINIRANU TERAPIJU KORTIKOSTROIDIMA
I CIKOFOSFAMIDOM
S A @ E T A K
Limfomatoidna granulomatoza (LG) danas se definira kao ekstranodalni angiocentri~ni i angiodestruktivni limfo-
proliferativni poreme}aj s razli~itim spektrom histolo{kog stupnja diferenciranosti i klini~ke agresije. Histolo{ki grad-
ing i klini~ki tijek ovise o broju atipi~nih velikih EBV+ B limfati~nih stanica. Prikazan je slu~aj 23-godi{njeg mladi}a s
izra`enim simptomima povi{ene temperature, poja~anog znojenja, intolerancije napora i dispneje, te s radiolo{ki verifi-
ciranim nodularnim i destruktivnim infiltratima plu}a obostrano, inicijalno tretiranim antituberkuloticima u trajanju
od 1,5 mjesec. Zbog progresijske dinamike bolesti dijagnostika je pro{irena na bronholo{ko uzimanje materijala trans-
bronhalnom biopsijom plu}a i perkutanu transtorakalnu punkciju lezija plu}a s citolo{kom i histolo{kom obradom
dobivenog materijala, {to nije bilo dovoljno za egzaktnu dijagnozu. LG je dokazana u uzorcima dobivenim otvorenom
biopsijom plu}a, nakon ~ega je provedena terapija kortikosteroidima i ciklofosfamidom. U nekoliko tjedana postignuto
je vrlo dobro klini~ko, laboratorijsko, funkcijsko i radiomorfolo{ko pobolj{anje, a remisija bolesti odr`ana je u du`em
periodu pra}enja.
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